MENU
RCEL
AS OF
Feb 4, 11:49 AM (EDT)
Price
$4.11
Change
-$0.19 (-4.42%)
Capitalization
131.12M
8 days until earnings call
Intraday BUY SELL Signals
+Compare
RCEL
Stock ticker: NASDAQ
AS OF
Feb 4, 11:49 AM (EDT)
Price
$4.11
Change
-$0.19 (-4.42%)
Capitalization
131.12M

RCEL Avita Medical Forecast, Technical & Fundamental Analysis

Avita is a single product company... Show more

RCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RCEL with price predictions
Feb 03, 2026

Momentum Indicator for RCEL turns positive, indicating new upward trend

RCEL saw its Momentum Indicator move above the 0 level on January 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 95 similar instances where the indicator turned positive. In of the 95 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

RCEL moved above its 50-day moving average on January 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RCEL crossed bullishly above the 50-day moving average on January 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RCEL advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RCEL moved out of overbought territory on January 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCEL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RCEL broke above its upper Bollinger Band on January 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for RCEL entered a downward trend on January 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RCEL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RCEL's P/B Ratio (54.054) is slightly higher than the industry average of (11.546). P/E Ratio (0.000) is within average values for comparable stocks, (38.420). RCEL's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.636). RCEL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (1.592) is also within normal values, averaging (38.937).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RCEL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
RCEL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RCEL is expected to report earnings to fall 18.39% to -37 cents per share on February 12

Avita Medical RCEL Stock Earnings Reports
Q4'25
Est.
$-0.38
Q3'25
Missed
by $0.20
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.21
Q4'24
Missed
by $0.10
The last earnings report on November 06 showed earnings per share of -46 cents, missing the estimate of -25 cents. With 436.51K shares outstanding, the current market capitalization sits at 131.12M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development and distribution of regenerative and respiratory medicine and treatments

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
28159 Avenue Stanford
Phone
+1 833 462-8482
Employees
207
Web
https://www.avitamedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFEIY4.66N/A
N/A
China Feihe Limited
FNNNF3.55N/A
N/A
Finnair OYJ
CIWV35.31-0.18
-0.51%
Citizens Financial Corp. (WV)
BRWC0.57-0.01
-1.32%
BIRDIE WIN CORP.
JXHLY16.60-0.29
-1.70%
Eneos Holdings Inc.

RCEL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RCEL has been loosely correlated with MRCHF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if RCEL jumps, then MRCHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-3.85%
MRCHF - RCEL
38%
Loosely correlated
N/A
MBOT - RCEL
33%
Poorly correlated
-1.11%
TRUMY - RCEL
31%
Poorly correlated
+1.22%
NTRA - RCEL
30%
Poorly correlated
-0.02%
SGHT - RCEL
30%
Poorly correlated
+2.55%
More

Groups containing RCEL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RCEL
1D Price
Change %
RCEL100%
-3.85%
Health Services
category (410 stocks)
5%
Poorly correlated
-0.91%
Medical/Nursing Services
category (216 stocks)
3%
Poorly correlated
-0.81%